AI in life sciences presents key opportunities in drug discovery, personalized medicine, and diagnostics by leveraging vast ...

The results of the clinical trial mark a setback for the Swiss pharmaceutical company, which saw in the drug, giredestrant, a ...

These companies have a lot more to offer than their prospects in the weight loss market.

AstraZeneca has also filed an oral SERD, camizestrant, targeting use of the drug in patients with advanced HR-positive breast ...

Zealand and Roche are jointly developing the drug petrelintide which in a mid-stage study led to a worse-than-expected 10.7% ...

Avastin, also known as bevacizumab, is a cancer medicine used in the treatment of recurrent glioblastoma in adults.The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted ...

Bayer CEO, Bill Anderson, warns against overestimating AI's ability to significantly reduce drug development timelines from 15 years to just 3.

Late-stage study finds Roche's giredestrant shows no improvement over standard therapy in preventing cancer progression.

He is the lead principal investigator of the ALLEGORY study and the lead author and he has also presented the results last Friday at SLEuro. Today, Dr. Richard Furie will take us again through the ...

Swiss pharma giant Roche has reported detailed Phase III results showing its B-cell therapy Gazyva (obinutuzumab) significantly improved outcomes for patients with systemic lupus erythematosus.

Implementing Digital pathology and AI in cancer diagnosis alleviates impact of pathologist shortage through improved workflow and remote collaboration capabilities ...

Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and T-cell engagers.